Deubiquitinating enzymes in cellular signaling and disease regulation

IUBMB Life

Volumn 67, Issue 7, 2015, Pages 544-555

  Hanpude, Pranita ^a   Bhattacharya, Sushmita ^a   Dey, Amit Kumar ^a   Maiti, Tushar Kanti ^a  

^a REGIONAL CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

cysteine proteases; deubiquitinating enzymes; enzyme mechanisms; neurodegenerative disorders; signaling; ubiquitin proteasome system

Indexed keywords

COLONY STIMULATING FACTOR 3 RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; DEUBIQUITINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ENZYME; RIBOSOME PROTEIN; RPS27A PROTEIN, HUMAN; UBB PROTEIN, HUMAN; UBIQUITIN;

CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; EMBRYONIC STEM CELL; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HISTONE MODIFICATION; HUMAN; INTRACELLULAR SIGNALING; NEOPLASM; NEUROLOGIC DISEASE; NUCLEOPHILICITY; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SUMOYLATION; UBIQUITINATION; CHEMISTRY; DEGENERATIVE DISEASE; DNA DAMAGE; DNA REPAIR; METABOLISM; OXIDATION REDUCTION REACTION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL;

DNA DAMAGE; DNA REPAIR; ENZYMES; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RIBOSOMAL PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; SUBSTRATE SPECIFICITY; SUMOYLATION; UBIQUITIN; UBIQUITINATION; UBIQUITINS;

EID: 84937840566     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1402     Document Type: Review

References (70)

1. Glickman, M. H., and, Ciechanover, A., (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373-428.
2. Welchman, R. L., Gordon, C., and, Mayer, R. J., (2005) Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Biol. 6, 599-609.
3. Hershko, A., and, Ciechanover, A., (1998) The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
4. Nijman, S. M., Luna-Vargas, M. P., Velds, A., Brummelkamp, T. R., Dirac, A. M., et al., (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786.
5. Chen, Z. J., and, Sun, L. J., (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell. 33, 275-286.
6. Ikeda, F., and, Dikic, I., (2008) Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep. 9, 536-542.
7. Komander, D., Clague, M. J., and, Urbe, S., (2009) Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10, 550-563.
8. Boudreaux, D. A., Chaney, J., Maiti, T. K., and, Das, C., (2012) Contribution of active site glutamine to rate enhancement in ubiquitin C-terminal hydrolases. Febs J. 279, 1106-1118.
9. Sato, Y., Yoshikawa, A., Yamagata, A., Mimura, H., Yamashita, M., et al., (2008) Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains. Nature 455, 358-362.
10. Arnold, J. J., Bernal, A., Uche, U., Sterner, D. E., Butt, T. R., et al., (2006) Small ubiquitin-like modifying protein isopeptidase assay based on poliovirus RNA polymerase activity. Anal. Biochem. 350, 214-221.
11. Artavanis-Tsakonas, K., Weihofen, W. A., Antos, J. M., Coleman, B. I., Comeaux, C. A., et al., (2010) Characterization and structural studies of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3. J. Biol. Chem. 285, 6857-6866.
12. Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J., and, Zhang, D. E., (2002) UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277, 9976-9981.
13. Olazabal-Herrero, A., Garcia-Santisteban, I., and, Rodriguez, J., (2015) Structure-function analysis of USP1: insights into the role of Ser313 phosphorylation site and the effect of cancer-associated mutations on autocleavage. Mol. Cancer 14, 33.
14. Mevissen, T. E., Hospenthal, M. K., Geurink, P. P., Elliott, P. R., Akutsu, M., et al., (2013) OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 154, 169-184.
15. Durcan, T. M., Tang, M. Y., Perusse, J. R., Dashti, E. A., Aguileta, M. A., et al., (2014) USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. Embo J. 33, 2473-2491.
16. Hu, M., Li, P., Li, M., Li, W., Yao, T., et al., (2002) Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111, 1041-1054.
17. Faesen, A. C., Dirac, A. M., Shanmugham, A., Ovaa, H., Perrakis, A., et al., (2011) Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Mol. Cell 44, 147-159.
18. Hu, M., Li, P., Song, L., Jeffrey, P. D., Chenova, T. A., et al., (2005) Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. Embo J. 24, 3747-3756.
19. Sato, Y., Goto, E., Shibata, Y., Kubota, Y., Yamagata, A., et al., (2015) Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity. Nat. Struct. Mol. Biol. 22, 222-229.
20. Johnston, S. C., Larsen, C. N., Cook, W. J., Wilkinson, K. D., and, Hill, C. P., (1997) Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution. Embo J. 16, 3787-3796.
21. Boudreaux, D. A., Maiti, T. K., Davies, C. W., and, Das, C., (2010) Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation. Proc. Natl. Acad. Sci. USA 107, 9117-9122.
22. Chen, X., and, Walters, K. J., (2015) Structural plasticity allows UCH37 to be primed by RPN13 or locked down by INO80G. Mol. Cell 57, 767-768.
23. Nishiyama, K., Murayama, S., Goto, J., Watanabe, M., Hashida, H., et al., (1996) Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals. Ann. Neurol. 40, 776-781.
24. Nicastro, G., Menon, R. P., Masino, L., Knowles, P. P., McDonald, N. Q., et al., (2005) The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc. Natl. Acad. Sci. USA 102, 10493-10498.
25. Agromayor, M., and, Martin-Serrano, J., (2006) Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo. J. Biol. Chem. 281, 23083-23091.
26. Pathare, G. R., Nagy, I., Sledz, P., Anderson, D. J., Zhou, H. J., et al., (2014) Crystal structure of the proteasomal deubiquitylation module Rpn8-Rpn11. Proc. Natl. Acad. Sci. USA 111, 2984-2989.
27. Hutti, J. E., Shen, R. R., Abbott, D. W., Zhou, A. Y., Sprott, K. M., et al., (2009) Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol. Cell 34, 461-472.
28. Hutti, J. E., Turk, B. E., Asara, J. M., Ma, A., Cantley, L. C., et al., (2007) IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol. Cell Biol 27, 7451-7461.
29. Mueller, T., Breuer, P., Schmitt, I., Walter, J., Evert, B. O., et al., (2009) CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum. Mol. Genet. 18, 3334-3343.
30. Khoronenkova, S. V., Dianova, I. I., Ternette, N., Kessler, B. M., Parsons, J. L., and, Dianov, G. L., (2012) ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage. Mol. Cell 45, 801-813.
31. Yuan, J., Luo, K., Zhang, L., Cheville, J. C., and, Lou, Z., (2010) USP10 regulates p53 localization and stability by deubiquitinating p53. Cell 140, 384-396.
32. Yu, H., Pak, H., Hammond-Martel, I., Ghram, M., Rodrigue, A., et al., (2014) Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 111, 285-290.
33. Zhou, Y. F., Liao, S. S., Luo, Y. Y., Tang, J. G., Wang, J. L., et al., (2013) SUMO-1 modification on K166 of polyQ-expanded ataxin-3 strengthens its stability and increases its cytotoxicity. PloS One 8, e54214.
34. Meray, R. K., and, Lansbury, P. T. Jr., (2007) Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J. Biol. Chem. 282, 10567-10575.
35. Mashtalir, N., Daou, S., Barbour, H., Sen, N. N., Gagnon, J., et al., (2014) Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. Mol. Cell 54, 392-406.
36. Kobayashi, T., Masoumi, K. C., and, Massoumi, R., (2015) Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells. Oncogene 34, 2251-2260.
37. Kulathu, Y., Garcia, F. J., Mevissen, T. E., Busch, M., Arnaudo, N., et al., (2013) Regulation of A20 and other OTU deubiquitinases by reversible oxidation. Nat. Commun. 4, 1569
38. Kabuta, T., Setsuie, R., Mitsui, T., Kinugawa, A., Sakurai, M., et al., (2008) Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum. Mol. Genet. 17, 1482-1496.
39. Koharudin, L. M., Liu, H., Di Maio, R., Kodali, R. B., Graham, S. H., et al., (2010) Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. Proc. Natl. Acad. Sci. USA 107, 6835-6840.
40. Contu, V. R., Kotake, Y., Toyama, T., Okuda, K., Miyara, M., et al., (2014) Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function. J. Neurochem. 130, 826-838.
41. Fischer-Vize, J. A., Rubin, G. M., and, Lehmann, R., (1992) The fat facets gene is required for Drosophila eye and embryo development. Development 116, 985-1000.
42. Jolly, L. A., Taylor, V., and, Wood, S. A., (2009) USP9X enhances the polarity and self-renewal of embryonic stem cell-derived neural progenitors. Mol. Biol. Cell 20, 2015-2029.
43. Knobeloch, K. P., Utermohlen, O., Kisser, A., Prinz, M., and, Horak, I., (2005) Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell Biol. 25, 11030-11034.
44. Scheuermann, J. C., de Ayala Alonso, A. G., Oktaba, K., Ly-Hartig, N., McGinty, R. K., et al., (2010) Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 465, 243-247.
45. Wang, L., and, Dent, S. Y., (2014) Functions of SAGA in development and disease. Epigenomics 6, 329-339.
46. Nandakumar, V., Chou, Y., Zang, L., Huang, X. F., and, Chen, S. Y., (2013) Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1. Proc. Natl. Acad. Sci. USA 110, E3927-3936.
47. Yang, W., Lee, Y. H., Jones, A. E., Woolnough, J. L., Zhou, D., et al., (2014) The histone H2A deubiquitinase Usp16 regulates embryonic stem cell gene expression and lineage commitment. Nat. Commun. 5, 3818.
48. Frangini, A., Sjoberg, M., Roman-Trufero, M., Dharmalingam, G., Haberle, V., et al., (2013) The aurora B kinase and the polycomb protein ring1B combine to regulate active promoters in quiescent lymphocytes. Mol. Cell 51, 647-661.
49. Zou, Q., Jin, J., Hu, H., Li, H. S., Romano, S., et al., (2014) USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat. Immunol. 15, 562-570.
50. Kim, J. M., Parmar, K., Huang, M., Weinstock, D. M., Ruit, C. A., et al., (2009) Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev. Cell. 16, 314-320.
51. Sharma, N., Zhu, Q., Wani, G., He, J., Wang, Q. E., et al., (2014) USP3 counteracts RNF168 via deubiquitinating H2A and gammaH2AX at lysine 13 and 15. Cell Cycle 13, 106-114.
52. Knobel, P. A., Belotserkovskaya, R., Galanty, Y., Schmidt, C. K., Jackson, S. P., et al., (2014) USP28 is recruited to sites of DNA damage by the tandem BRCT domains of 53BP1 but plays a minor role in double-strand break metabolism. Mol. Cell Biol. 34, 2062-2074.
53. Rathaus, M., Lerrer, B., and, Cohen, H. Y., (2009) DeubiKuitylation: a novel DUB enzymatic activity for the DNA repair protein, Ku70. Cell Cycle 8, 1843-1852.
54. Maertens, G. N., El Messaoudi-Aubert, S., Elderkin, S., Hiom, K., and, Peters, G., (2010) Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. Embo J. 29, 2553-2565.
55. Joo, H. Y., Zhai, L., Yang, C., Nie, S., Erdjument-Bromage, H., et al., (2007) Regulation of cell cycle progression and gene expression by H2A deubiquitination. Nature 449, 1068-1072.
56. Lee, J., Jee, C., Lee, J. I., Lee, M. H., Lee, M. H., et al., (2001) A deubiquitinating enzyme, UCH/CeUBP130, has an essential role in the formation of a functional microtubule-organizing centre (MTOC) during early cleavage in C. elegans. Genes Cells 6, 899-911.
57. Atanassov, B. S., and, Dent, S. Y., (2011) USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1. EMBO Rep. 12, 924-930.
58. Atanassov, B. S., Evrard, Y. A., Multani, A. S., Zhang, Z., Tora, L., et al., (2009) Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance. Mol. Cell 35, 352-364.
59. Nicassio, F., Corrado, N., Vissers, J. H., Areces, L. B., Bergink, S., et al., (2007) Human USP3 is a chromatin modifier required for S phase progression and genome stability. Curr. Biol. 17, 1972-1977.
60. Zhang, Y., Foreman, O., Wigle, D. A., Kosari, F., Vasmatzis, G., et al., (2012) USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. J. Clin. Invest. 122, 4362-4374.
61. Sun, X. X., and, Dai, M. S., (2014) Deubiquitinating enzyme regulation of the p53 pathway: a lesson from Otub1. World J. Biol. Chem. 5, 75-84.
62. De, A., Dainichi, T., Rathinam, C. V., and, Ghosh, S., (2014) The deubiquitinase activity of A20 is dispensable for NF-kappaB signaling. EMBO Rep. 15, 775-783.
63. Herhaus, L., and, Sapkota, G. P., (2014) The emerging roles of deubiquitylating enzymes (DUBs) in the TGFbeta and BMP pathways. Cell Signal. 26, 2186-2192.
64. Meenhuis, A., Verwijmeren, C., Roovers, O., and, Touw, I. P., (2011) The deubiquitinating enzyme DUB2A enhances CSF3 signalling by attenuating lysosomal routing of the CSF3 receptor. Biochem. J. 434, 343-351.
65. Bhattacharyya, B. J., Wilson, S. M., Jung, H., and, Miller, R. J., (2012) Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14. Am. J. Physiol. Cell Physiol. 302, C698 -C 708.
66. Imai, S., Mamiya, T., Tsukada, A., Sakai, Y., Mouri, A., et al., (2012) Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system. PloS One 7, e39084.
67. Xilouri, M., Kyratzi, E., Pitychoutis, P. M., Papadopoulou-Daifoti, Z., Perier, C., et al., (2012) Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system. Hum. Mol. Genet. 21, 874-889.
68. Zhao, Y., Thornton, A. M., Kinney, M. C., Ma, C. A., Spinner, J. J., et al., (2011) The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor beta (TGF-beta) signaling and the development of regulatory T cells. J. Biol. Chem. 286, 40520-40530.
69. Yuasa-Kawada, J., Kinoshita-Kawada, M., Rao, Y., and, Wu, J. Y., (2009) Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration. Proc. Natl. Acad. Sci. USA 106, 14530-14535.
70. Charan, R. A., Hanson, R., and, Clemens, P. R., (2012) Deubiquitinating enzyme A20 negatively regulates NF-kappaB signaling in skeletal muscle in mdx mice. Faseb J. 26, 587-595.